secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001860742-23-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q3 revenue $1.007B, raises full-year 2023 revenue and EBITDA guidance
--------------------------------------------------------------------------------

- Q3 revenue $1.007B (+7% YoY, +8% constant currency); GAAP net loss of $84M vs $18M loss prior year.
- Adjusted EBITDA $187M (flat YoY); adjusted EPS $0.22 (vs $0.31 prior year).
- Full-year 2023 revenue guidance raised to $4.035-$4.085B; Adjusted EBITDA guidance raised to $710-$760M.
- Vision Care revenue rose 9% to $648M; Surgical up 8% to $185M; Pharmaceuticals flat at $174M.
- Launched MIEBO for dry eye and acquired XIIDRA; distribution system upgrade impacted contact lens sales, expected to resolve in Q1 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074223000026/0001860742-23-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074223000026/blco-20231101.htm
  HTML page:      https://secwatch.observer/filing/0001860742-23-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer